Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
CagriSema demonstrated superior HbA1c reduction of 1.91 points and weight loss of 14.2% in adults with type 2 diabetes in the REIMAGINE 2 trial
Trulicity is prescribed as a treatment for diabetes and for off-label weight-loss purposes
In a combined multiple ascending dose and Phase IIa study in people with type 2 diabetes over 41 days, daily doses of cotadutide up to 200 g improved fasting and postprandial glucose levels and reduced body weight compared with placebo [79]
Response timing varies: some patients feel appetite suppression within 2-3 days, while others require 2-3 weeks of consistent dosing to experience noticeable effects
Another frequent concern is the fear of self-injection
US$ 28.01
US$ 27.66
US$ 28.44
US$ 28.38
US$ 23.29
